Labeling of 
the stemCARE Platform by GIS IBiSA

Home  > 

Labeling of the stemCARE Platform by GIS IBiSA

Founded in 2007, the Scientific Interest Group (GIS) IBiSA plays a crucial role in coordinating the national policy for labeling and supporting national research infrastructures in biology and health. As the only common funding instrument for all partner institutions in life sciences, GIS IBiSA ensures the quality and accessibility of labeled platforms and CRBs to the scientific community.

For the 2024 edition of its call for proposals, GIS IBiSA has defined several priority themes, including pluripotent stem cells. Among the structures specialized in this field, the stemCARE technology platform, led by Alexandra Benchoua, has been selected for labeling.

This labeling provides stemCARE with top-tier recognition within the scientific community and opens up future funding opportunities, particularly for the purchase of expensive equipment. The stemCARE platform is distinguished by its six integrated technological units:

  • Cell Culture and Genomic Integrity Control
  • Genome Editing
  • Bioproduction
  • NGS
  • Cellular Imaging
  • High-Throughput Screening

stemCARE offers the creation, bioproduction, and cryopreservation of cellular models for genetic diseases based on human pluripotent stem cells and their progeny. It supports users in studying the molecular and functional disorders associated with these diseases through high-throughput sequencing technologies and advanced analytical platforms. Additionally, stemCARE assists in the search for potential pharmacological compounds by screening repositionable molecules or new chemical entities in partnership with collection owners.

The platform also provides training on culture techniques, quality control, and the use of equipment independently.